President Trump said at a roundtable Monday that he's been taking the antimalarial drug hydroxychloroquine and a zinc supplement for "about a week and a half" as a preventative measure against the coronavirus.

Why it matters: The FDA issued a warning last month that the unproven drug should only be taken in hospitals because of the risk of heart complications. There's no substantiated evidence that taking hydroxychloroquine prevents COVID-19 infections.

The big picture: Rick Bright, the former head of a key government vaccine agency, testified last week that he believes he was ousted from his position because of his resistance to promoting hydroxychloroquine, which has long been touted by Trump and his allies in conservative media.

  • Bright said that he supported the use of hydroxychloroquine under the supervision of a physician. But when HHS leadership issued a directive to make the drug more broadly available, Bright says he resisted: "I did not think it was the proper or safe way to evaluate that drug in the context of this outbreak."
  • Hydroxychloroquine is currently being studied as a potential preventative for health care workers with high risk of exposure to coronavirus patients.

What he's saying:

"I asked [the White House doctor], what do you think? He said if you'd like it. I said yeah, I'd like it. A lot of front-line workers are taking hydroxychloroquine. I don't take it because — hey, people said oh maybe he owns the company. No, I don't own the company. I want the people of this nation to feel good. I don't want them being sick. And there is a very good chance that this has an impact, especially early on. But you look at front-line workers. You look at doctors and nurses. A lot of them are taking it. As a preventative."

DISCLAIMER: READ THE FDA's WARNINGS ABOUT HYDROXYCHLOROQUINE

Go deeper

22 hours ago - Podcasts

Russia’s vaccine gamble

Russia announced Tuesday that it approved a vaccine for COVID-19 and has plans to inoculate health care workers, teachers and others in the coming months, despite barely starting Phase 3 clinical trials.

Axios Re:Cap digs into the ramifications of this announcement for the global vaccine race with Derek Lowe, medicinal chemist, author and expert on drug development and the pharmaceutical industry.

12 hours ago - Health

America's flying blind on its coronavirus response

Illustration: Aïda Amer/Axios

A month after the Trump administration changed how hospital data is reported, the public release of this data "has slowed to a crawl," the Wall Street Journal reports.

The big picture: This is the latest example of how the world's wealthiest country just can't get it together.

21 hours ago - Health

Fauci says he "seriously" doubts Russia's coronavirus vaccine is safe

NIAID director Anthony Fauci testifies during a July congressional hearing on Capitol Hill. Photo: Kevin DietschI/AFP via Getty Images

NIAID director Anthony Fauci cast doubt during a National Geographic discussion due to air this week on the effectiveness of Russia's registered coronavirus vaccine touted by President Vladimir Putin on Tuesday.

Why it matters: "Having a vaccine ... and proving that a vaccine is safe and effective are two different things," Fauci told told ABC News' Deborah Roberts in the discussion, expected to air on Thursday. His comments add to the weight of skepticism from scientists around the world on the Russia vaccine. There is no published scientific to support support Putin's claims.